1 |
Newman, D.J., G.M. Cragg, and K.M. Snader, Natural products as sources of new drugs over the period 1981-2002. J Nat Prod, 66(7), 1022-37 (2003).
DOI
ScienceOn
|
2 |
Paduch, R., et al., Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz), 55(5), 315-27 (2007).
DOI
ScienceOn
|
3 |
Liby, K.T., M.M. Yore, and M.B. Sporn, Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer, 7(5), 357-69 (2007).
DOI
ScienceOn
|
4 |
Alakurtti, S., et al., Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci, 29(1), 1-13 (2006).
DOI
ScienceOn
|
5 |
Fulda, S. and G. Kroemer, Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov Today, 14(17-18), 885-90 (2009).
DOI
ScienceOn
|
6 |
Santos, R.C., et al., New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells. Biochimie, 93(6), 1065-75 (2011).
DOI
ScienceOn
|
7 |
Fulda, S., Betulinic Acid for cancer treatment and prevention. Int J Mol Sci, 9(6), 1096-107 (2008).
DOI
ScienceOn
|
8 |
Thurnher, D., et al., Betulinic acid: a new cytotoxic compound against malignant head and neck cancer cells. Head Neck, 25(9), 732-40 (2003).
DOI
ScienceOn
|
9 |
Kaye, F.J., Mutation-associated fusion cancer genes in solid tumors. Mol Cancer Ther, 8(6), 1399-408 (2009).
DOI
ScienceOn
|
10 |
Chang, W.C. and J.J. Hung, Functional role of post-translational modifications of Sp1 in tumorigenesis. J Biomed Sci, 19, 94 (2012).
DOI
|
11 |
Saxena, A., et al., Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression. Cancer Lett, 251(1), 114-31 (2007).
DOI
ScienceOn
|
12 |
Dasgupta, P., et al., Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci U S A, 103(16), 6332-7 (2006).
DOI
ScienceOn
|
13 |
Virrey, J.J., et al., Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol, 173(2), 575-85 (2008).
DOI
ScienceOn
|
14 |
Li, F., Role of survivin and its splice variants in tumorigenesis. Br J Cancer, 92(2), 212-6 (2005).
|
15 |
Zhou, P., et al., Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosisinducing conditions. Blood, 89(2), 630-43 (1997).
|
16 |
Moulding, D.A., et al., Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood, 96(5), 1756-63 (2000).
|
17 |
Yuan, P., et al., Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer, 110(12), 2682-90 (2007).
DOI
ScienceOn
|
18 |
Wei, L.H., et al., The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene, 20(41), 5799-809 (2001).
DOI
ScienceOn
|
19 |
Abdelrahim, M., et al., Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem, 277(32), 28815-22 (2002).
DOI
ScienceOn
|
20 |
Abdelrahim, M. and S. Safe, Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol, 68(2), 317-29 (2005).
|
21 |
Oh, J.E., J.A. Han, and E.S. Hwang, Downregulation of transcription factor, Sp1, during cellular senescence. Biochem Biophys Res Commun, 353(1), 86-91 (2007).
DOI
ScienceOn
|
22 |
Ishibashi, H., et al., Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res, 60(22), 6531-6 (2000).
|
23 |
Lou, Z., et al., Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res, 65(3), 1007-17 (2005).
|
24 |
Adrian, G.S., et al., YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner. J Gerontol A Biol Sci Med Sci, 51(1), B66-75 (1996).
|
25 |
Deveraux, Q.L. and J.C. Reed, IAP family proteins--suppressors of apoptosis. Genes Dev, 13(3), 239-52 (1999).
DOI
ScienceOn
|
26 |
Li, F., Survivin study: what is the next wave? J Cell Physiol, 197(1), 8-29 (2003).
DOI
ScienceOn
|
27 |
Altieri, D.C., Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res, 5, 447-52 (2003).
|
28 |
Li, F. and M.G. Brattain, Role of the Survivin gene in pathophysiology. Am J Pathol, 169(1), 1-11 (2006).
DOI
ScienceOn
|
29 |
Shin, J.A., et al., Apoptotic effect of Polygonum Cuspidatum in oral cancer cells through the regulation of specificity protein 1. Oral Dis, 17(2), 162-70 (2011).
DOI
ScienceOn
|
30 |
McHugh, C.H., et al., Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer, 118(16), 3928-36 (2012).
DOI
ScienceOn
|
31 |
Cichewicz, R.H. and S.A. Kouzi, Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev, 24(1), 90-114 (2004).
DOI
ScienceOn
|
32 |
Chiosea, S.I., et al., Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch, 452(6), 629-35 (2008).
DOI
|
33 |
Enlund, F., et al., Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res, 292(1), 21-8 (2004).
DOI
ScienceOn
|
34 |
Behboudi, A., et al., Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer, 45(5), 470-81 (2006).
DOI
ScienceOn
|
35 |
Galluzzi, L., et al., Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene, 25(34), 4812-30 (2006).
DOI
ScienceOn
|
36 |
Zuco, V., et al., Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett, 175(1), 17-25 (2002).
DOI
ScienceOn
|
37 |
Fulda, S., et al., Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr, 211(4), 319-22 (1999).
DOI
ScienceOn
|
38 |
Suske, G., The Sp-family of transcription factors. Gene, 238(2), 291-300 (1999).
DOI
ScienceOn
|
39 |
Black, A.R., J.D. Black, and J. Azizkhan-Clifford, Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol, 188(2), 143-60 (2001).
DOI
ScienceOn
|
40 |
Nance, M.A., et al., Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer,. 113(8), 2082-9 (2008).
DOI
ScienceOn
|